Chang Xia
- Geriatrics and Gerontology top 1%
- Sirtuins and Resveratrol in Medicine 2
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism 5
- Biochemistry top 5%
- Eicosanoids and Hypertension Pharmacology 2
- Molecular Biology top 10%
- Epigenetics and DNA Methylation 2
- Protein Degradation and Inhibitors 2
- PI3K/AKT/mTOR signaling in cancer 2
- Histone Deacetylase Inhibitors Research 2
- Physiology top 10%
-
- MRI in cancer diagnosis 1
- Co-authors
- Bing‐Hua JiangJing FangMeng QiaoYon RojanasakulXianglin ShiLiu LZongxian CaoG. Keith Harris
- Partner nations
- United StatesChina
In The Last Decade
Chang Xia
14 papers receiving 1.9k citations
Hit Papers
Peers
Comparison fields: 5 of 109
- Geriatrics and Gerontology 334
- Cancer Research 441
- Biochemistry 149
- Molecular Biology 1.1k
- Physiology 49
Countries citing papers authored by Chang Xia
This map shows the geographic impact of Chang Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chang Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chang Xia more than expected).
Fields of papers citing papers by Chang Xia
This network shows the impact of papers produced by Chang Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chang Xia. The network helps show where Chang Xia may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Chang Xia, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 6 | |
| 2 | 2014 | 55 | |
| 3 | 2014 | 13 | |
| 4 | 2014 | 0 | |
| 5 | 2013 | 16 | |
| 6 | 2012 | 2 | |
| 7 | Generation of streptavidin-tagged human-granulocyte macrophage colony-stimulating factor fusion proteins. | 2012 | 1 |
| 8 | 2007 | 407 | |
| 9 | 2006 | 169 | |
| 10 | 2006 | 61 | |
| 11 | 2006 | 184 | |
| 12 | 2005 | 270 | |
| 13 | 2004 | 140 | |
| 14 | Resveratrol scavenges reactive oxygen species and effects radical-induced cellular responsesbreakdown → | 2003 | 577 |
| 15 | Evaluation of Clinical Usage of Bicyclol in the Treatment of Chronic HCV | 2003 | 2 |
About Chang Xia
Chang Xia is a scholar working on Geriatrics and Gerontology, Cancer Research and Biochemistry, having authored 15 papers that have together received 1.9k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (5 papers), Sirtuins and Resveratrol in Medicine (2 papers), Epigenetics and DNA Methylation (2 papers), Eicosanoids and Hypertension Pharmacology (2 papers), Protein Degradation and Inhibitors (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers), Histone Deacetylase Inhibitors Research (2 papers) and MRI in cancer diagnosis (1 paper). The work is most often cited by research in Geriatrics and Gerontology (334 citations), Cancer Research (441 citations) and Biochemistry (149 citations). Chang Xia has collaborated with scholars based in United States and China. Frequent co-authors include Bing‐Hua Jiang, Jing Fang, Meng Qiao, Yon Rojanasakul, Xianglin Shi, Liu L, Zongxian Cao, G. Keith Harris, H. Klandorf and Stephen S. Leonard.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.